Bioengineered
Volume 12, 2021 - Issue 2
Open access
1,763
Views
4
CrossRef citations to date
0
Altmetric
Research Paper
Nuclear receptor binding SET domain protein 1 promotes epithelial-mesenchymal transition in paclitaxel-resistant breast cancer cells via regulating nuclear factor kappa B and F-box and leucine-rich repeat protein 11
Yi Chena Department of Oncology, Nanjing Pukou Central Hospital, the First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, ChinaView further author information
, Weiwei Tangb Hepatobiliary/Liver Transplantation Center, The First Affiliated Hospital of Nanjing Medical University, Key Laboratory of Living Donor Transplantation, Chinese Academy of Medical Sciences, Nanjing, Jiangsu, ChinaView further author information
, Xuedan Zhuc Department of Oncology, Nanjing First Hospital, Nanjing Medical University, Nanjing, Jiangsu, ChinaView further author information
, Lele Zhangd Department of Nuclear Medicine, Nanjing First Hospital, Nanjing Medical University, Nanjing, Jiangsu, ChinaView further author information
, Yinxing Zhuc Department of Oncology, Nanjing First Hospital, Nanjing Medical University, Nanjing, Jiangsu, ChinaView further author information
, Hua Xiaoe Department of General Surgery, Nanjing First Hospital, Nanjing Medical University, Nanjing, Jiangsu, ChinaView further author information
, Jin Xuf Department of Thyroid and Mammary Gland Surgery, Nanjing First Hospital, Nanjing Medical University, Nanjing, Jiangsu, ChinaView further author information
, Yueyu Fanga Department of Oncology, Nanjing Pukou Central Hospital, the First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu, ChinaView further author information
, Xiao Lif Department of Thyroid and Mammary Gland Surgery, Nanjing First Hospital, Nanjing Medical University, Nanjing, Jiangsu, ChinaView further author information
, Cuiju Tangc Department of Oncology, Nanjing First Hospital, Nanjing Medical University, Nanjing, Jiangsu, ChinaCorrespondence[email protected]
https://orcid.org/0000-0002-7162-8618View further author information
Junfeng Shic Department of Oncology, Nanjing First Hospital, Nanjing Medical University, Nanjing, Jiangsu, ChinaCorrespondence[email protected]
View further author information
show allView further author information
Pages 11506-11519
|
Received 16 Sep 2021, Accepted 18 Nov 2021, Published online: 14 Dec 2021
Reprints and Permissions
This is an open access article distributed under the terms of the Creative Commons CC BY license, which permits unrestricted use, distribution, reproduction in any medium, provided the original work is properly cited.
You are not required to obtain permission to reuse this article in part or whole.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.